As the global economy recovers in 2021 and the supply of the industrial chain improves, the Hybrid Positron Emission Tomography (PET) Systems market will undergo major changes. According to the latest research, the market size of the Hybrid Positron Emission Tomography (PET) Systems industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Hybrid Positron Emission Tomography (PET) Systems industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Hybrid Positron Emission Tomography (PET) Systems market during the next few years. The global Hybrid Positron Emission Tomography (PET) Systems market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of Hybrid Positron Emission Tomography (PET) Systems market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Direct Imaging
Indirect Imaging
Alternative Imaging
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Diagnostic Imaging Centers
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Koninklijke Philips
Canon Medical Systems Corporation
General Electric
Siemens Healthcare
FUJIFILM Holdings Corporation
Bruker
Hitachi
Mediso
Rigaku
Cubresa
Abbott
Medtronic
CMR Naviscan
Agfa-Gevaert Group
Oncovision
Neusoft Corporation
MinFound Medical Systems
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Hybrid Positron Emission Tomography (PET) Systems by Country/Region, 2017, 2022 & 2028
2.2 Hybrid Positron Emission Tomography (PET) Systems Segment by Type
2.2.1 Direct Imaging
2.2.2 Indirect Imaging
2.2.3 Alternative Imaging
2.3 Hybrid Positron Emission Tomography (PET) Systems Sales by Type
2.3.1 Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Type (2017-2022)
2.3.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue and Market Share by Type (2017-2022)
2.3.3 Global Hybrid Positron Emission Tomography (PET) Systems Sale Price by Type (2017-2022)
2.4 Hybrid Positron Emission Tomography (PET) Systems Segment by Application
2.4.1 Hospitals
2.4.2 Diagnostic Imaging Centers
2.4.3 Others
2.5 Hybrid Positron Emission Tomography (PET) Systems Sales by Application
2.5.1 Global Hybrid Positron Emission Tomography (PET) Systems Sale Market Share by Application (2017-2022)
2.5.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue and Market Share by Application (2017-2022)
2.5.3 Global Hybrid Positron Emission Tomography (PET) Systems Sale Price by Application (2017-2022)
3 Global Hybrid Positron Emission Tomography (PET) Systems by Company
3.1 Global Hybrid Positron Emission Tomography (PET) Systems Breakdown Data by Company
3.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Annual Sales by Company (2020-2022)
3.1.2 Global Hybrid Positron Emission Tomography (PET) Systems Sales Market Share by Company (2020-2022)
3.2 Global Hybrid Positron Emission Tomography (PET) Systems Annual Revenue by Company (2020-2022)
3.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Revenue by Company (2020-2022)
3.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Revenue Market Share by Company (2020-2022)
3.3 Global Hybrid Positron Emission Tomography (PET) Systems Sale Price by Company
3.4 Key Manufacturers Hybrid Positron Emission Tomography (PET) Systems Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Hybrid Positron Emission Tomography (PET) Systems Product Location Distribution
3.4.2 Players Hybrid Positron Emission Tomography (PET) Systems Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region
4.1 World Historic Hybrid Positron Emission Tomography (PET) Systems Market Size by Geographic Region (2017-2022)
4.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Hybrid Positron Emission Tomography (PET) Systems Annual Revenue by Geographic Region
4.2 World Historic Hybrid Positron Emission Tomography (PET) Systems Market Size by Country/Region (2017-2022)
4.2.1 Global Hybrid Positron Emission Tomography (PET) Systems Annual Sales by Country/Region (2017-2022)
4.2.2 Global Hybrid Positron Emission Tomography (PET) Systems Annual Revenue by Country/Region
4.3 Americas Hybrid Positron Emission Tomography (PET) Systems Sales Growth
4.4 APAC Hybrid Positron Emission Tomography (PET) Systems Sales Growth
4.5 Europe Hybrid Positron Emission Tomography (PET) Systems Sales Growth
4.6 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales Growth
5 Americas
5.1 Americas Hybrid Positron Emission Tomography (PET) Systems Sales by Country
5.1.1 Americas Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2017-2022)
5.1.2 Americas Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2017-2022)
5.2 Americas Hybrid Positron Emission Tomography (PET) Systems Sales by Type
5.3 Americas Hybrid Positron Emission Tomography (PET) Systems Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hybrid Positron Emission Tomography (PET) Systems Sales by Region
6.1.1 APAC Hybrid Positron Emission Tomography (PET) Systems Sales by Region (2017-2022)
6.1.2 APAC Hybrid Positron Emission Tomography (PET) Systems Revenue by Region (2017-2022)
6.2 APAC Hybrid Positron Emission Tomography (PET) Systems Sales by Type
6.3 APAC Hybrid Positron Emission Tomography (PET) Systems Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Hybrid Positron Emission Tomography (PET) Systems by Country
7.1.1 Europe Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2017-2022)
7.1.2 Europe Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2017-2022)
7.2 Europe Hybrid Positron Emission Tomography (PET) Systems Sales by Type
7.3 Europe Hybrid Positron Emission Tomography (PET) Systems Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems by Country
8.1.1 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales by Country (2017-2022)
8.1.2 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Revenue by Country (2017-2022)
8.2 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales by Type
8.3 Middle East & Africa Hybrid Positron Emission Tomography (PET) Systems Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Hybrid Positron Emission Tomography (PET) Systems
10.3 Manufacturing Process Analysis of Hybrid Positron Emission Tomography (PET) Systems
10.4 Industry Chain Structure of Hybrid Positron Emission Tomography (PET) Systems
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Hybrid Positron Emission Tomography (PET) Systems Distributors
11.3 Hybrid Positron Emission Tomography (PET) Systems Customer
12 World Forecast Review for Hybrid Positron Emission Tomography (PET) Systems by Geographic Region
12.1 Global Hybrid Positron Emission Tomography (PET) Systems Market Size Forecast by Region
12.1.1 Global Hybrid Positron Emission Tomography (PET) Systems Forecast by Region (2023-2028)
12.1.2 Global Hybrid Positron Emission Tomography (PET) Systems Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Hybrid Positron Emission Tomography (PET) Systems Forecast by Type
12.7 Global Hybrid Positron Emission Tomography (PET) Systems Forecast by Application
13 Key Players Analysis
13.1 Koninklijke Philips
13.1.1 Koninklijke Philips Company Information
13.1.2 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.1.3 Koninklijke Philips Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Koninklijke Philips Main Business Overview
13.1.5 Koninklijke Philips Latest Developments
13.2 Canon Medical Systems Corporation
13.2.1 Canon Medical Systems Corporation Company Information
13.2.2 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.2.3 Canon Medical Systems Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Canon Medical Systems Corporation Main Business Overview
13.2.5 Canon Medical Systems Corporation Latest Developments
13.3 General Electric
13.3.1 General Electric Company Information
13.3.2 General Electric Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.3.3 General Electric Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 General Electric Main Business Overview
13.3.5 General Electric Latest Developments
13.4 Siemens Healthcare
13.4.1 Siemens Healthcare Company Information
13.4.2 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.4.3 Siemens Healthcare Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Siemens Healthcare Main Business Overview
13.4.5 Siemens Healthcare Latest Developments
13.5 FUJIFILM Holdings Corporation
13.5.1 FUJIFILM Holdings Corporation Company Information
13.5.2 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.5.3 FUJIFILM Holdings Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 FUJIFILM Holdings Corporation Main Business Overview
13.5.5 FUJIFILM Holdings Corporation Latest Developments
13.6 Bruker
13.6.1 Bruker Company Information
13.6.2 Bruker Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.6.3 Bruker Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Bruker Main Business Overview
13.6.5 Bruker Latest Developments
13.7 Hitachi
13.7.1 Hitachi Company Information
13.7.2 Hitachi Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.7.3 Hitachi Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Hitachi Main Business Overview
13.7.5 Hitachi Latest Developments
13.8 Mediso
13.8.1 Mediso Company Information
13.8.2 Mediso Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.8.3 Mediso Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mediso Main Business Overview
13.8.5 Mediso Latest Developments
13.9 Rigaku
13.9.1 Rigaku Company Information
13.9.2 Rigaku Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.9.3 Rigaku Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Rigaku Main Business Overview
13.9.5 Rigaku Latest Developments
13.10 Cubresa
13.10.1 Cubresa Company Information
13.10.2 Cubresa Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.10.3 Cubresa Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Cubresa Main Business Overview
13.10.5 Cubresa Latest Developments
13.11 Abbott
13.11.1 Abbott Company Information
13.11.2 Abbott Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.11.3 Abbott Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Abbott Main Business Overview
13.11.5 Abbott Latest Developments
13.12 Medtronic
13.12.1 Medtronic Company Information
13.12.2 Medtronic Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.12.3 Medtronic Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Medtronic Main Business Overview
13.12.5 Medtronic Latest Developments
13.13 CMR Naviscan
13.13.1 CMR Naviscan Company Information
13.13.2 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.13.3 CMR Naviscan Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CMR Naviscan Main Business Overview
13.13.5 CMR Naviscan Latest Developments
13.14 Agfa-Gevaert Group
13.14.1 Agfa-Gevaert Group Company Information
13.14.2 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.14.3 Agfa-Gevaert Group Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Agfa-Gevaert Group Main Business Overview
13.14.5 Agfa-Gevaert Group Latest Developments
13.15 Oncovision
13.15.1 Oncovision Company Information
13.15.2 Oncovision Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.15.3 Oncovision Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Oncovision Main Business Overview
13.15.5 Oncovision Latest Developments
13.16 Neusoft Corporation
13.16.1 Neusoft Corporation Company Information
13.16.2 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.16.3 Neusoft Corporation Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Neusoft Corporation Main Business Overview
13.16.5 Neusoft Corporation Latest Developments
13.17 MinFound Medical Systems
13.17.1 MinFound Medical Systems Company Information
13.17.2 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Product Offered
13.17.3 MinFound Medical Systems Hybrid Positron Emission Tomography (PET) Systems Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 MinFound Medical Systems Main Business Overview
13.17.5 MinFound Medical Systems Latest Developments
14 Research Findings and Conclusion
Koninklijke Philips
Canon Medical Systems Corporation
General Electric
Siemens Healthcare
FUJIFILM Holdings Corporation
Bruker
Hitachi
Mediso
Rigaku
Cubresa
Abbott
Medtronic
CMR Naviscan
Agfa-Gevaert Group
Oncovision
Neusoft Corporation
MinFound Medical Systems
*If Applicable.